Lavinia Margarit

3.1k total citations
26 papers, 402 citations indexed

About

Lavinia Margarit is a scholar working on Immunology, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Lavinia Margarit has authored 26 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Reproductive Medicine and 6 papers in Obstetrics and Gynecology. Recurrent topics in Lavinia Margarit's work include Reproductive System and Pregnancy (9 papers), Endometriosis Research and Treatment (5 papers) and Pregnancy and preeclampsia studies (4 papers). Lavinia Margarit is often cited by papers focused on Reproductive System and Pregnancy (9 papers), Endometriosis Research and Treatment (5 papers) and Pregnancy and preeclampsia studies (4 papers). Lavinia Margarit collaborates with scholars based in United Kingdom, Greece and United States. Lavinia Margarit's co-authors include Deyarina González, R. Steven Conlan, Lewis W. Francis, C. A. Davies, J.O. White, Lisa Joels, Adnan Bunkheila, Jetzabel García-Parra, Mark H. Roberts and A.G. Brenton and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, British Journal of Cancer and Human Reproduction.

In The Last Decade

Lavinia Margarit

26 papers receiving 392 citations

Peers

Countries citing papers authored by Lavinia Margarit

Since Specialization

Citations

This map shows the geographic impact of Lavinia Margarit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lavinia Margarit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lavinia Margarit more than expected).

Fields of papers citing papers by Lavinia Margarit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lavinia Margarit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lavinia Margarit. The network helps show where Lavinia Margarit may publish in the future.

Co-authorship network of co-authors of Lavinia Margarit

This figure shows the co-authorship network connecting the top 25 collaborators of Lavinia Margarit. A scholar is included among the top collaborators of Lavinia Margarit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lavinia Margarit. Lavinia Margarit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer 2024 ·Cell Communication and Signaling ·(unknown), David Howard, (unknown), (unknown), Jetzabel García-Parra, (unknown), (unknown), (unknown), (unknown), Lavinia Margarit, Lewis W. Francis, R. Steven Conlan, Francesca Taraballi, Deyarina González	4
2	In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer 2023 ·British Journal of Cancer ·(unknown), David W. James, (unknown), (unknown), Lavinia Margarit, Nagindra Das, (unknown), (unknown), Inmaculada Rioja, Rab K. Prinjha, Nicola Harker, Deyarina González, R. Steven Conlan, Lewis W. Francis	2
3	Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells 2023 ·Clinical Epigenetics ·(unknown), David W. James, (unknown), Lydia C. Powell, (unknown), (unknown), (unknown), Neil Garton, Nagindra Das, (unknown), Lavinia Margarit, (unknown), Inmaculada Rioja, Rab K. Prinjha, Nicola Harker, Deyarina González, R. Steven Conlan, Lewis W. Francis	4
4	Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer 2022 ·Frontiers in Oncology ·David Howard, David H. James, Jetzabel García-Parra, (unknown), Jenny Worthington, Nicole Williams, (unknown), (unknown), (unknown), Lewis W. Francis, Paul Rees, Lavinia Margarit, R. Steven Conlan, Deyarina González	10
5	Dinaciclib, a Bimodal Agent Effective against Endometrial Cancer 2021 ·Cancers ·David Howard, David H. James, Kate Murphy, Jetzabel García-Parra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lavinia Margarit, Lewis W. Francis, Paul Rees, Deyarina González, R. Steven Conlan	10
6	Chronic Urinary Infection in Overactive Bladder Syndrome: A Prospective, Blinded Case Control Study 2021 ·Frontiers in Cellular and Infection Microbiology ·Zainab Khan, Gareth D. Healey, (unknown), (unknown), (unknown), Lavinia Margarit, Deyarina González, Simon Emery, R. Steven Conlan	6
7	Highly glycosylated MUC1 mediates high affinity L-selectin binding at the human endometrial surface 2021 ·Journal of Nanobiotechnology ·Lewis W. Francis, (unknown), Lydia C. Powell, (unknown), (unknown), Thomas M. Piasecki, W E Howe, (unknown), Mary C. Farach‐Carson, Pamela E. Constantinou, Daniel D. Carson, Lavinia Margarit, Deyarina González, R. Steven Conlan	8
8	Non-invasive molecular assessment of human embryo development and implantation potential 2020 ·Biosensors and Bioelectronics ·(unknown), (unknown), (unknown), Adnan Bunkheila, Andrea Cruz, Sofia Rodrigues Teixeira, Pedro Alpuim, Lewis W. Francis, (unknown), (unknown), Lavinia Margarit, Deyarina González, P. P. Freitas, R. Steven Conlan, Inês Mendes Pinto	13
9	Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients 2020 ·Journal of Molecular Medicine ·(unknown), (unknown), (unknown), Lewis W. Francis, (unknown), (unknown), (unknown), R. Steven Conlan, Deyarina González, Lavinia Margarit	24
10	Cu isotope ratios are meaningful in ovarian cancer diagnosis 2020 ·Journal of Trace Elements in Medicine and Biology ·(unknown), Alexandra T. Gourlan, Philippe Télouk, (unknown), Lewis W. Francis, R. Steven Conlan, Lavinia Margarit, Deyarina González, Laurent Charlet	33
11	Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors 2019 ·Biosensors and Bioelectronics ·Sofia Rodrigues Teixeira, (unknown), (unknown), Julia M. Davies, (unknown), (unknown), Lavinia Margarit, Deyarina González, Inês Mendes Pinto, Lewis W. Francis, R. Steven Conlan	10
12	Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11 2019 ·Journal of Molecular Medicine ·(unknown), (unknown), (unknown), Jetzabel García-Parra, (unknown), Helen Whiteland, Adnan Bunkheila, Lewis W. Francis, Lavinia Margarit, Deyarina González, R. Steven Conlan	39
13	Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer 2019 ·Journal for ImmunoTherapy of Cancer ·Gareth D. Healey, (unknown), Jetzabel García-Parra, Julia M. Davies, Shaun Roberts, (unknown), K. K. Dhar, (unknown), (unknown), (unknown), Richard Clarkson, Gillian Seaton, Åsa Frostell, (unknown), (unknown), Lavinia Margarit, R. Steven Conlan, Deyarina González	22
14	Morphophysical dynamics of human endometrial cells during decidualization 2018 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Salvatore A. Gazzè, (unknown), Christopher D. Lucas, Lavinia Margarit, Deyarina González, Lewis W. Francis, R. Steven Conlan	41
15	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment 2016 ·Interface Focus ·David Howard, Jetzabel García-Parra, Gareth D. Healey, (unknown), Lavinia Margarit, Lewis W. Francis, Deyarina González, R. Steven Conlan	16
16	Progestins and the Onset of Cervical Vasculitis in a Patient with Ankylosing Spondylitis 2016 ·Lavinia Margarit, Deyarina González, (unknown), (unknown), (unknown), (unknown)	1
17	MUC1 as a Discriminator between Endometrium from Fertile and Infertile Patients with PCOS and Endometriosis 2010 ·The Journal of Clinical Endocrinology & Metabolism ·Lavinia Margarit, Angela E. Taylor, Mark H. Roberts, (unknown), C. A. Davies, A.G. Brenton, R. Steven Conlan, Adnan Bunkheila, Lisa Joels, J.O. White, Deyarina González	69
18	L-Selectin ligands in human endometrium: comparison of fertile and infertile subjects 2009 ·Human Reproduction ·Lavinia Margarit, Deyarina González, Paul D. Lewis, (unknown), C. A. Davies, R. Steven Conlan, Lisa Joels, J.O. White	50
19	Amniotic fluid endothelin levels and the incidence of premature rupture of membranes 2006 ·International Journal of Gynecology & Obstetrics ·Lavinia Margarit, A Griffiths, V. Tsapanos, Sotiris Tsakas, George Decavalas	3
20	Second trimester amniotic fluid endothelin concentration. A possible predictor for pre-eclampsia 2005 ·Journal of Obstetrics and Gynaecology ·Lavinia Margarit, A Griffiths, V. Tsapanos, George Decavalas, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact